Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia

Background: Colesevelam hydrochloride is a novel, lipid‐lowering agent that binds bile acids with high affinity. A multicenter, randomized, double‐blind, placebo‐controlled, parallel‐design study was conducted to assess the efficacy and tolerability of combination low‐dose colesevelam and lovastatin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cardiol
Päätekijät: Davidson, Michael H., Toth, Phillip, Weiss, Stuart, Mckenney, James, Hunninghake, Donald, Isaacsohn, Jonathan, Donovan, Joanne M., Burke, Steven K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wiley Periodicals, Inc. 2009
Aiheet:
Clinical Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6655189/
https://ncbi.nlm.nih.gov/pubmed/11403509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960240610
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia